Longevity Health Holdings Inc.

$0.32+0.00%(+$0.00)
TickerSpark Score
52/100
Mixed
80
Valuation
60
Profitability
55
Growth
36
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XAGE research report →

52-Week Range1% of range
Low $0.23
Current $0.32
High $8.27

Companywww.carmellcosmetics.com

Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

CEO
Janakiram Ajjarapu
IPO
2021
Employees
15
HQ
Pittsburgh, PA, US

Price Chart

-90.18% · this period
$5.78$3.02$0.25May 20Nov 18May 20

Valuation

Market Cap
$457.62K
P/E
-0.09
P/S
0.26
P/B
-0.09
EV/EBITDA
-0.08
Div Yield
0.00%

Profitability

Gross Margin
57.11%
Op Margin
-397.16%
Net Margin
-380.73%
ROE
133.44%
ROIC
109.73%

Growth & Income

Revenue
$1.91M · 3701.44%
Net Income
$-6,905,282 · 33.40%
EPS
$-4.01 · -702.00%
Op Income
$-7,107,573
FCF YoY
23.82%

Performance & Tape

52W High
$8.27
52W Low
$0.23
50D MA
$0.34
200D MA
$0.75
Beta
0.38
Avg Volume
2.27K

Get TickerSpark's AI analysis on XAGE

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Mar 16, 26Ajjarapu J. Rambuy689,656
Mar 16, 26Ajjarapu J. Ramother0
Oct 11, 24Bracken-Ferguson Kendraother378,705
Oct 11, 24Cassaday Bryan J.other120,000
Oct 11, 24Spenlehauer Gillesother76,878
Oct 11, 24Sturgeon Patrick Aother76,878
Oct 11, 24Upton Richard Aother76,878
Oct 11, 24Gregory Kathrynother76,878
Oct 11, 24Shukla Rajivother876,878
Oct 11, 24Frisch Scott M.other76,878

Our XAGE Coverage

We haven't published any research on XAGE yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate XAGE Report →

Similar Companies